Stock PLX PROTALIX BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Protalix BioTherapeutics, Inc. TEL AVIV STOCK EXCHANGE

Equities

PLX

US74365A3095

Delayed TEL AVIV STOCK EXCHANGE
Other stock markets
 15:24:48 21/03/2023 GMT 		5-day change 1st Jan Change
732.5 ILa -.--% Intraday chart for Protalix BioTherapeutics, Inc. +3.29% +69.68%
05-10 Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024
05-10 Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
AQ
Protalix BioTherapeutics : PLX Corporate Presentation (May 2024)
PU
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results
AQ
Protalix: Q1 Earnings Snapshot
AQ
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
AQ
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
AQ
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
AQ
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference
AQ
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results
AQ
Protalix: Q3 Earnings Snapshot
AQ
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023
AQ
Protalix BioTherapeutics : PLX Corporate Presentation (October 2023)
PU
Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel
AQ
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
AQ
Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
AQ
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results
AQ
Protalix BioTherapeutics : PLX Corporate Presentation (August 2023)
PU
Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
AQ
Protalix BioTherapeutics to Announce Second Quarter 2023 Financial and Business Results on August 7, 2023
AQ
Protalix BioTherapeutics : PLX Corporate Presentation (May 2023)
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLX Stock
  4. PLX Stock
  5. News Protalix BioTherapeutics, Inc.
  6. Press Releases
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW